Sanchez, Katherine
Englander, Hanna
Salloum, Lana
Gregoire, Samantha
Biba, Ursula
Ershadi, Sherry
Mostaghimi, Arash https://orcid.org/0000-0002-6084-5617
Article History
Received: 29 June 2025
Accepted: 4 August 2025
First Online: 12 August 2025
Declarations
:
: Dr. Arash Mostaghimi has received consulting fees from AbbVie, ACOM Health, Bioniz, Boehringer Ingelheim, Concert, Digital Diagnostics, Eli Lilly, Equillium, Hims & Hers Health, and Pfizer; equity from ACOM Health, Figure-1, and Hims & Hers Health; licensing/royalties from Concert and Pfizer; and research funding from Aclaris, Concert, Eli Lilly, and Incyte. Dr. Arash Mostaghimi is a member of the Editorial Board for Dermatology and Therapy. Dr. Arash Mostaghimi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Katherine Sanchez, Hanna Englander, Lana Salloum, Samantha Gregoire, Ursula Biba, and Sherry Ershadi have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.